Download Files:
Rifasutenizol
$718 – $5,495
Products Details
Product Description
– Rifasutenizol (TNP-2198) is a potent and orally bioavailable dual-targeted antibacterial agent. Rifasutenizol has potent activity against microaerophilic and anaerobic bacterial pathogens[1].
Web ID
– HY-144300
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C48H61N7O13
References
– [1]Ma Z, et al. Design, Synthesis, and Characterization of TNP-2198, a Dual-Targeted Rifamycin-Nitroimidazole Conjugate with Potent Activity against Microaerophilic and Anaerobic Bacterial Pathogens. J Med Chem. 2022;65(6):4481-4495.
CAS Number
– 1001314-13-1
Molecular Weight
– 944.04
SMILES
– O=C(C)O[C@H]1[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(C(NC(C(C2=C3C4=C(O[C@](C)(O/C=C/[C@H](OC)[C@H]1C)C4=O)C(C)=C2O)=O)=C5C3=NC6(CCN(CCN7C([N+]([O-])=O)=CN=C7C)CC6)N5)=O)/C
Clinical Information
– Phase 3
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– Bacterial
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
